FindMyKOL
Clinical trialNCT01607073CompletedPhase 2Interventional

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

SponsorGillette Children's Specialty HealthcareEnrollment2Dravet Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S Memorial Hospital

    Chicago, Illinois, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Gillette Children'S Specialty Healthcare

    Saint Paul, Minnesota, United States

  • Mary Hitchcock Memorial Hospital

    Lebanon, New Hampshire, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Verapamil →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2012
Primary completion
31 Jan 2015
Completion
31 Jan 2015
Last update posted
13 Apr 2021
Registered enrollment
2
Registry id
NCT01607073
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.